Herein, we showed that the miR-655-3p antagomir activated AMPKα via upregulating FNDC5, and FNDC5 silence blocked the miR-655-3p antagomir-mediated AMPKα activation and hepatoprotective effects against NAFLD. Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.